Aortic & peripheral vascular disease

Health status and cognitive function for risk stratification in chronic coronary and peripheral artery disease

Eur J Prev CardiolPublished Secondary analysis of the COMPASS randomised trial

Authors' conclusion

Adding health status and cognitive functioning information to biomedical evaluations can augment cardiovascular risk-stratification in CAD and PAD.

Study context

Population
Stable coronary artery disease (CAD) and peripheral artery disease (PAD) patients from the COMPASS trial
Participants
23,433 vs 6,899
Comparison
Higher vs lower EQ visual analogue scale (VAS) health status and Digit Symbol Substitution test (DSST) cognitive function scores
  • CADn = 23,433
  • PADn = 6,899
Primary endpoint
Incident MACE, and combined MACE or major adverse limb events
Methodological detailsinternational, multi-centre, fully adjusted hierarchical Cox regression
  • International
  • Multi-centre
  • Fully adjusted hierarchical Cox regression

Primary result

As reported in the abstract

MACE or major adverse limb events
Hazard ratio (95% CI)
CADEQ VAS, per 10 unit increase
0.89(0.88–0.89)
PADEQ VAS, per 10 unit increase
0.89(0.88–0.89)
CADDSST, per 5 unit increase
0.95(0.94–0.95)
PADDSST, per 5 unit increase
0.95(0.94–0.95)

Each row per its own increment, as printed

Further findings

Population attributable risk, lower two vs upper quartiles

EQ-5D

DSST

Original publication

Health status and cognitive function for risk stratification in chronic coronary and peripheral artery disease. Eur J Prev Cardiol. Published 29 November 2022. doi:10.1093/eurjpc/zwac282

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.